Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

  • Midas B. Mulder (Contributor)
  • Erwin Birnie (Creator)
  • Caroline van Dijck–van Boetzelaer (Contributor)
  • Gert-Jan van de Geijn (Contributor)
  • Egbert Boeve (Creator)
  • Elsbeth M. Westerman (Creator)
  • Paul Hamberg (Creator)

Dataset

Description

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)
Datum van beschikbaarheid26-dec.-2020
UitgeverTaylor & Francis Group

Contact

Toegang dataset

Citeer dit